Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
04/2003
04/09/2003EP1299123A2 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
04/09/2003EP1299092A2 Use of fluorescein derivatives for the treatment of diseases responsive to the activation of the cystic fibrosis transmembrane conductance regulator chloride channel
04/09/2003EP1091950B1 Substituted benzopyran derivatives and their use as anticonvulsants
04/09/2003EP0906303B1 Ring-fused dihydropyranes, process for the preparation and use thereof
04/09/2003EP0758327B1 Pyranone compounds useful to treat retroviral infections
04/09/2003CN1104897C Hesperidin and hesperetin as 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase inhibitor
04/08/2003US6545049 E.g., (2E, 4E, 6E)-7-(3,5-diisopropyl-2-n-heptyloxyphenyl)-3-methylocta-2,4,6-trienoic acid, esters or amides thereof
04/08/2003US6545040 Method of lowering the blood pressure
04/08/2003US6544951 Antiinflammatory agents; autoimmune diseases, nervous system degradation
04/08/2003US6544566 For prophylaxis and minimizing development of atherosclerosis
04/03/2003US20030065197 Process for producing benzopyran carboxamide
04/03/2003US20030065189 Heating, cyclization
04/03/2003US20030065018 Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
04/03/2003US20030064972 Using thiazolidinone compound
04/03/2003US20030064938 Cardiovascular disorders; menstraution disorders; anticancer agents
04/03/2003US20030064098 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
04/02/2003EP1298129A2 Process for producing 4-sustituted benzopyran derivatives
04/02/2003EP1297835A1 Benzo[b]pyrano[3,2-h]acridin-7-one derivatives, processes for their preparation and pharmaceutical compositions thereof
04/02/2003EP1212312B1 Novel derivatives of flavones, xanthones and coumarins
04/02/2003EP0954519B1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof
04/02/2003EP0894089B9 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
04/02/2003EP0882029B1 Heterocyclic derivatives as antidiabetic and antiobesity agents
04/02/2003EP0873295B1 Dimer-selective rxr modulators and methods for their use
04/02/2003CN1407979A Fluorescent probes for quantitation of zinc
04/02/2003CN1104412C Benzamidine derivatives and use thereof as medicaments with LTB4-antagonistic effect
04/02/2003CN1104202C Aglucone isoflavone enriched vegetable protein extract and isolate and process for producing
04/01/2003US6541613 Isoflavone for use in treatment of cancer, osteoporosis and autoimmune diseases; for use in nutrients
04/01/2003US6541510 Cannabichromene derivative is exposed to the virus, a host cell, or an infected cell under conditions sufficient to inhibit the replication or proliferation of the virus, especially HIV.
04/01/2003US6541229 Use for better preservation of red blood cells during storage and increased viability in vivo following transfusion
03/2003
03/27/2003WO2003025017A1 Cytokine receptor
03/27/2003WO2003024955A2 Small molecule inhibitors of caspases
03/27/2003WO2003024952A1 Bioprecursors for percutaneous application
03/27/2003WO2003024951A1 Flavonol and cysteine conjugates
03/27/2003WO2003024950A1 Coumarin derivative
03/27/2003WO2003024949A1 Dna-pk inhibitors
03/27/2003WO2003024943A2 Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis
03/27/2003WO2003024448A2 Inhibitors of histone deacetylase
03/27/2003WO2003024183A2 Wortmannin analogs and methods of using same
03/27/2003WO2003002715A3 Compositions and methods for labeling oligonucleotides
03/27/2003WO2002089781A3 Methods of treating hyperlipidemia
03/27/2003US20030060469 Use of substances that act as cascade inhibitors of the raf/mek/erk signal cascade, for producing a medicament to treat dna and rna viruses
03/27/2003US20030059785 Detection of markers in nascent proteins
03/27/2003CA2465978A1 Inhibitors of histone deacetylase
03/27/2003CA2460783A1 Bioprecursors for percutaneous application
03/27/2003CA2460151A1 Cytokine receptor
03/27/2003CA2454023A1 Dna-pk inhibitors in the treatment of retroviral mediated diseases
03/26/2003EP1295877A1 Xanthone derivatives, preparation processes thereof, their use as fungicides and compositions containing them
03/26/2003EP1294658A1 Process for the preparation of nitroalkenes
03/26/2003EP1212315B1 Novel chalcones
03/26/2003EP1212311B1 Chalcone coumarins
03/26/2003EP1114043B1 Naphthopyrans annelated in c 6?-c 7?, their preparation and compositions and (co)polymer matrices containing them
03/26/2003EP1105384B1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
03/26/2003EP1098893B1 Cyclic compounds useful in the treatment of dyslipidemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process
03/26/2003EP0977748B1 Substituted benzopyran derivatives for the treatment of inflammation
03/26/2003EP0969822B1 Determination of the propensity of an organ or tissue for cancer by determining of its imprinting pattern
03/26/2003EP0930310B1 Isocoumarin derivatives and use thereof in drugs
03/26/2003EP0801640B1 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
03/26/2003CN1405165A Method for preventing oxidation of ginkgo leaf extractive
03/26/2003CN1405164A Corter pseudolaricis acid derivatives, preparation method and use thereof
03/26/2003CN1103768C Process for preparing 2H-1-benzopyrans compound
03/25/2003US6538149 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo [1,2-g]chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
03/25/2003US6538021 Method for producing luteolin and luteolin derivatives
03/25/2003US6538003 Pyridopyranoazepine derivatives, their preparation and their therapeutic application
03/25/2003CA2079466C Novel benzopyran derivatives and an anti-allergic agent possessing the same as the active ingrediant
03/20/2003WO2003022994A2 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto
03/20/2003WO2002074758A3 Novel amines as histamine-3 receptor ligands and their therapeutic applications
03/20/2003US20030055257 Water-soluble rhodamine dye conjugates
03/20/2003US20030055243 Atropisomers of asymmetric xanthene fluorescent dyes and methods of DNA sequencing and fragment analysis
03/20/2003US20030055056 For use as antitumor and immune suppressive agents, as inhibitors of proliferative cell growth and as prophylactic agents to inhibit and prevent cancer and non-malignant cell growth
03/20/2003US20030054974 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
03/20/2003US20030054549 Cell propagation mixture for use in the activation of stem cells
03/20/2003US20030054291 Multilayer; radiation transparent substrate, recording media, reflective layer and protective coatings
03/20/2003US20030052310 Perfluorinated amide salts and their uses as ionic conducting materials
03/19/2003EP1292589A2 Methods for producing chiral chromones, chromanes, amino substituted chromanes and intermediates therefor
03/19/2003EP1292588A1 Methods for resolving chiral (2s) and (2r) chromanes
03/19/2003EP1292573A2 Substituted thioacetamides
03/19/2003EP1292298A1 Intracorporeal medicaments for high energy phototherapeutic treatment of disease
03/19/2003EP1292194A2 An improved method for extracting cocoa procyanidins
03/19/2003EP1178984B1 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
03/19/2003CN1404484A Pluraflavins and derivatives thereof, process for their preparation and use thereof
03/19/2003CN1403452A Astragalus calycosin and its glycoside with the function of resisting myocardial ischemia
03/19/2003CN1403451A Balsamiferous biumea general flavone extractive and its extraction process and medicinal application
03/18/2003CA2162708C Bicyclic amide derivatives and their use as muscle relaxants
03/13/2003WO2003020860A2 Methods for treating deodorizer distillate
03/13/2003WO2003020291A1 Increased solubility flavanolignan preparations
03/13/2003WO2003020259A2 Combinations of dmxaa and other anti-cancer agents
03/13/2003WO2003020031A1 Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce mechanical degradation of intervertebral disc and other collagenous tissues
03/13/2003WO2002078625A3 Therapeutic combinations for cardiovascular and inflammatory indications
03/13/2003US20030050334 Supercritical fluid extraction of Delta-9- THC, Delta-8-THC and related cannabinoids from marijuana plants using liquid carbon dioxide as a supercritical fluid
03/13/2003US20030050308 Eltoprazine hydrochloride (1-(2,3-dihyro-1,4-benzodioxin-5-yl) piperazine hydrochloride), a phenylpiperazine derivative
03/13/2003US20030049301 Crosslinking collage
03/13/2003CA2458963A1 Increased solubility flavanolignan preparations
03/13/2003CA2458459A1 Anti-cancer combinations
03/12/2003EP1289929A1 Shortened synthesis of 3,3-diarylpropylamine derivatives
03/12/2003EP1289556A2 Phytoestrogenic isoflavone compositions
03/12/2003EP1175415A4 Synthetic methods for preparing procyanidin oligomers
03/12/2003EP0992239B1 Neuropeptide y receptor antagonist
03/12/2003EP0672031B1 Catechol diethers as selective pde iv inhibitors
03/12/2003EP0670835B1 Process for preparing benzopyran compounds
03/12/2003CN1402719A Method for preparing DL-alpha-tocopherol with high yield and high purity
1 ... 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 ... 242